The DOI matches its Crossref record; 173 of the 173 references it cites were found in a registry or an index; 79 of the 136 sources its claims cite were checked for support.
Connecting metabolome and phenotype: recent advances in functional metabolomics tools for the identification of bioactive natural products
Open accessAbstract
Covering: 1995 to 2023Advances in bioanalytical methods, particularly mass spectrometry, have provided valuable molecular insights into the mechanisms of life. Non-targeted metabolomics aims to detect and (relatively) quantify all observable small molecules present in a biological system. By comparing small molecule abundances between different conditions or timepoints in a biological system, researchers can generate new hypotheses and begin to understand causes of observed phenotypes. Functional metabolomics aims to investigate the functional roles of metabolites at the scale of the metabolome. However, most functional metabolomics studies rely on indirect measurements and correlation analyses, which leads to ambiguity in the precise definition of functional metabolomics. In contrast, the field of natural products has a history of identifying the structures and bioactivities of primary and specialized metabolites. Here, we propose to expand and reframe functional metabolomics by integrating concepts from the fields of natural products and chemical biology. We highlight emerging functional metabolomics approaches that shift the focus from correlation to physical interactions, and we discuss how this allows researchers to uncover causal relationships between molecules and phenotypes.
Overview
CoChat Summary
## TL;DR
This perspective argues that functional metabolomics should move beyond correlation-based associations toward workflows that directly capture physical interactions and chemical reactions between metabolites and biological targets. It surveys experimental and computational tools—especially those adapted from natural products research—to connect molecules to phenotypes and prioritize bioactive compounds.
## Key findings
- The paper frames most current functional metabolomics as indirect: many workflows infer function from gene deletions, knockdowns, or enrichment analyses rather than measuring metabolite function directly.
- It highlights a range of tools that shift toward causality, including affinity-selection MS, native metabolomics, NMR-based approaches, stable-isotope labeling/flux analysis, and bioactivity-based metabolomics.
- In correlation-based studies, the authors cite a functional metabolomics pipeline that revealed functions of 4913 genes in *Saccharomyces cerevisiae* and another CRISPRi study of 30 E. coli strains that showed localized metabolic buffering of enzyme perturbations.
- For computational deconvolution, the paper notes that public MS/MS spectral libraries in MassBank, MassBank of North America, and GNPS contain 587,213 experimental MS/MS reference spectra in aggregate.
## Methods
- Perspective/review article covering literature from 1995 to 2023, synthesizing advances in functional metabolomics and natural products discovery.
- The paper organizes methods into experimental and computational categories, including correlation/guilt-by-association, bioactivity-based metabolomics, metabolic flux analysis and stable isotope labeling, affinity-based metabolomics, native metabolomics, chemical metabolomics, and machine-learning-based structure/activity prediction.
- It does not report a new original dataset; instead, it reviews prior studies and compares how different workflows infer metabolite function and bioactivity.
## Limitations
- The paper states that many functional metabolomics studies rely on indirect measurements and correlation analyses, which creates ambiguity in the definition of “functional metabolomics.”
- It also notes that a major bottleneck remains the limited compound identification rate due to restricted spectral-library coverage, incomplete understanding of MS/MS fragmentation, and sometimes insufficient CID fragmentation.
- Evident from the text: because this is a perspective/review, it does not present a single unified experimental protocol or new empirical validation of the proposed framework.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures











Verification
Claims the paper makes
57 Valid · 4 Not valid · 23 Not checked · 13 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“Offline methods have the advantage that even compounds suffering from slow binding kinetics can be assigned.”
§ Connecting metabolome and phenotype: recent advances in functional metabolomics tools for the identification of bioactive natural products > Functional metabolomics strategies > Bioactivity-based metabolomics approaches
What the sources say
- Supportedcites [55] source
The Abstract says the offline format can identify compounds with slow binding kinetics because it permits the long incubation times they require. The Evaluation section reports successful analysis of slow-binding bungarotoxin after a three-hour postcolumn incubation, directly supporting the stated advantage. (LLM, conf=0.94)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Many functional metabolomics studies do not measure functional properties of the metabolites themselves, but rather determine function using correlation and “guilt by association” with other known bioactive metabolites, transcription, or protein expression”
§ Connecting metabolome and phenotype: recent advances in functional metabolomics tools for the identification of bioactive natural products > Introduction
What the sources say
- Partly supportedcites [16] sourceExperimental — accuracy not yet measured
Split into 2 atoms — 0 confirmed, 2 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
- Partly supportedcites [17] sourceExperimental — accuracy not yet measured
Split into 2 atoms — 0 confirmed, 2 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
- Partly supportedcites [18] sourceExperimental — accuracy not yet measured
Split into 2 atoms — 1 confirmed, 1 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“These approaches have been successful in guiding the isolation of novel compounds with specific activity (e.g., antibacterial or antiviral).”
§ Connecting metabolome and phenotype: recent advances in functional metabolomics tools for the identification of bioactive natural products > Functional metabolomics strategies > Bioactivity-based metabolomics approaches
What the sources say
- Partly supportedcites [32] sourceExperimental — accuracy not yet measured
The results (p. 5) report that bioactive molecular networking guided the isolation of four new compounds, two of which selectively inhibited chikungunya virus replication. This supports the antiviral example, but our copy does not show that the approach guided isolation of antibacterial compounds. (LLM, conf=0.84)
- Partly supportedcites [51] sourceExperimental — accuracy not yet measured
The paper reports discovering eight new albicidin derivatives using a bioactivity-guided molecular networking approach (p. 2). Its workflow selected fractions with antibacterial activity (Communication, p. 3). This supports the antibacterial example, but our copy does not report antiviral activity or an antiviral discovery. (LLM, conf=0.86)
- Partly supportedcites [52] sourceExperimental — accuracy not yet measured
In Molecular Explorer (page not provided), molecular networking guided the purification of a previously undescribed stenothricin analog, which was subsequently found active against a specific bacterial cell type. The paper does not describe bioactivity-based selection guiding that isolation or an antiviral example. (LLM, conf=0.85)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Well-designed flux analysis experiments can help deconvolute the measurements such that distribution of flux corresponding to different pathways leading to the formation of same product can be calculated.”
§ Connecting metabolome and phenotype: recent advances in functional metabolomics tools for the identification of bioactive natural products > Functional metabolomics strategies > Metabolic flux analysis and stable isotope labeling
What the sources say
- Supportedcites [65] source
The Introduction (page not provided) says metabolic flux analysis can quantify flux splits between parallel pathways that produce the same intermediate. The Abstract adds that parallel pathways require isotopic-labeling experiments, consistent with the claim’s qualification that the experiments must be well designed. (LLM, conf=0.91)
plainstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Besides the study of metabolic flux of primary metabolism, the use of stable isotope tracers has been widely applied in the natural product field. Both, for the discovery and structure elucidation of metabolites as well as the investigation of their biosynthetic origin, the use of stable isotope is a powerful tool.”
§ Connecting metabolome and phenotype: recent advances in functional metabolomics tools for the identification of bioactive natural products > Functional metabolomics strategies > Metabolic flux analysis and stable isotope labeling
What the sources say
- Partly supportedcites [66] sourceExperimental — accuracy not yet measured
The Introduction (page unavailable) says isotope labeling has historically been used to determine compounds’ biosynthetic origins. The Discussion (page unavailable) describes using stable-isotope incorporation to discover novel natural-product variants. Our copy does not establish the claim that stable-isotope tracers are widely used for structure elucidation; it describes MS and NMR as the chemical-characterization methods in its example. (LLM, conf=0.84)
- Not checked — no full text of the sourcecites [67] source
boosted- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
50 more claims · 31 with their cited sources checked
Create a free account to see all 97 claims and to verify the 1 reference still open.
- It may state two separate claims as one. 28
- The quote only partly states this claim. 1
- Probably not a substantial claim. 19
Citations
Cites
Methods for in vitro evaluating antimicrobial activity: A review
Balouiri, M., Sadiki, M., & Ibnsouda, S. K. (2016) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2015.11.005 · Cited by 8,044
Natural products in drug discovery: advances and opportunities
Atanasov, A. G., Zotchev, S. B., Dirsch, V. M., Taskforce, T. I. N. P. S., Orhan, I. E., Banach, M., Rollinger, J. M., Barreca, D., Weckwerth, W., Bauer, R., et al. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-00114-z · Cited by 5,392
The HCV Life Cycle: In vitro Tissue Culture Systems and Therapeutic Targets
Gerold, G., & Pietschmann, T. (2014) · Digestive Diseases · doi:10.1159/000360830 · Cited by 4,854
Wang, M., Carver, J. J., Phelan, V. V., Sanchez, L. M., Garg, N., Peng, Y., Nguyen, D. D., Watrous, J., Kapono, C. A., Luzzatto-Knaan, T., et al. (2016) · Nature Biotechnology · doi:10.1038/nbt.3597 · Cited by 4,629
Self-citationRoss, P. L., Huang, Y. N., Marchese, J. N., Williamson, B., Parker, K., Hattan, S., Khainovski, N., Pillai, S., Dey, S., Daniels, S., et al. (2004) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m400129-mcp200 · Cited by 4,401
Molecular Docking: A Powerful Approach for Structure-Based Drug Discovery
Meng, X.-Y., Zhang, H.-X., Mezei, M., & Cui, M. (2011) · Current Computer Aided-Drug Design · doi:10.2174/157340911795677602 · Cited by 3,771
ZINC 15 – Ligand Discovery for Everyone
Sterling, T., & Irwin, J. J. (2015) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.5b00559 · Cited by 3,224
Metabolomics: beyond biomarkers and towards mechanisms
Johnson, C. H., Ivanisevic, J., & Siuzdak, G. (2016) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2016.25 · Cited by 2,829
Metabolomics: the apogee of the omics trilogy
Patti, G. J., Yanes, O., & Siuzdak, G. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3314 · Cited by 2,571
MassBank: a public repository for sharing mass spectral data for life sciences
Horai, H., Arita, M., Kanaya, S., Nihei, Y., Ikeda, T., Suwa, K., Ojima, Y., Tanaka, K., Tanaka, S., Aoshima, K., et al. (2010) · Journal of Mass Spectrometry · doi:10.1002/jms.1777 · Cited by 2,529
Research works printed but not linked: 3
- World Health Organization , WHO global report on traditional and complementary medicine 2019 , World Health Organization , Geneva , 2019
- Genilloud, 2019, Antimicrobials, 51, 81
- Huang, 2015, Proc. Natl. Acad. Sci. U. S. A., 112, E1974
Cited by
New drug discovery and development from natural products: Advances and strategies
Wang, Y., Wang, F., Liu, W., Geng, Y., Shi, Y., Yu, T., Zhang, B., Luo, Y., & Sun, X. (2024) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2024.108752 · Cited by 111
Metabolomics‐driven approaches for identifying therapeutic targets in drug discovery
Pan, S., Yin, L., Liu, J., Tong, J., Wang, Z., Zhao, J., Liu, X., Chen, Y., Miao, J., Zhou, Y., et al. (2024) · MedComm · doi:10.1002/mco2.792 · Cited by 59
“Functional metabolomics, also known as activity metabolomics, 113 is a specialized discipline that inter-sects with phenotyping.”
BackgroundSharma, A., Das, N., Pandey, P., & Shukla, P. (2025) · Current Plant Biology · doi:10.1016/j.cpb.2025.100513 · Cited by 46
Mass spectrometry-based metabolomic as a powerful tool to unravel the component and mechanism in TCM
Liao, G., Tang, H., Yu, Y., Fu, L., Li, S.-J., & Zhu, M. (2025) · Chinese Medicine · doi:10.1186/s13020-025-01112-2 · Cited by 42
“The choice of tracer and labeling pattern depends on the specific metabolic flux under investigation [86, 99].”
Marine specialized metabolites: Unveiling Nature's chemical treasures from the deep blue
Jayawardena, T. U., Mérindol, N., Liyanage, N. S., Awwad, F., & Desgagné‐Penix, I. (2024) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2024.118097 · Cited by 25
Metadata
- Authors
- Vitale, G. A., Geibel, C., Minda, V., Wang, M., Aron, A. T., & Petras, D.
- Affiliations
- University of Tübingen (DE)
- University of Denver (US)
- University of California, Riverside (US)
- Corresponding author
- Wang, Mingxun
- Aron, Allegra T.
- Petras, Daniel
- ORCID
- Venue
- Natural Product Reports
- Publisher
- Royal Society of Chemistry (RSC)
- Published
- 2024
- Volume
- 41
- Issue
- 6
- Pages
- 885-904
- ISSN
- 0265-0568 (ISSN-L)
- 1460-4752
- PMC
- PMC11186733
- OpenAlex
- W4391816699
- Cited by
- 66
- References
- 172
- Citations by year
- 2026: 32 · 2025: 26 · 2024: 8
- FWCI
- 2.69
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Natural Product Reports (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information) (submittedVersion)
- Funders
- Deutsche Forschungsgemeinschaft (CMFI Cluster of Excellence (EXC 2124), Collaborative Research Center CellMap (TRR 261))
- University of California, Riverside
- National Institutes of Health (5U24DK133658-02)
- Joint Genome Institute
- U.S. Department of Energy (DE-AC02-05CH11231)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolomics and Mass Spectrometry Studies
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Physical Sciences › Chemistry › Spectroscopy › Mass Spectrometry Techniques and Applications
- Keywords
- natural products, untargeted metabolomics, small molecule interactions, chemical biology, bioactive natural products
- MeSH terms
- Biological Products, Phenotype, Mass Spectrometry, Molecular Structure, Metabolomics, Metabolome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Connecting metabolome and phenotype: recent advances in functional metabolomics tools for the identification of bioactive natural products. https://app.cochat.ai/papers/10.1039/d3np00050h
- The paper
- Vitale, G. A., Geibel, C., Minda, V., Wang, M., Aron, A. T., & Petras, D. (2024). Connecting metabolome and phenotype: recent advances in functional metabolomics tools for the identification of bioactive natural products. Natural Product Reports. https://doi.org/10.1039/d3np00050h
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.